Log in to save to my catalogue

Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19...

Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_075d60a7a4074e35b070c9194fc6a79a

Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

Limited evidence exists on the role of glucose-lowering drugs in patients with COVID-19. Our main objective was to examine the association between in-hospital death and each routine at-home glucose-lowering drug both individually and in combination with metformin in patients with type 2 diabetes mellitus admitted for COVID-19. We also evaluated the...

Alternative Titles

Full title

Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_075d60a7a4074e35b070c9194fc6a79a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_075d60a7a4074e35b070c9194fc6a79a

Other Identifiers

ISSN

1741-7015

E-ISSN

1741-7015

DOI

10.1186/s12916-020-01832-2

How to access this item